federal securities

‘Pharma Bro’ defies advice to keep quiet before fraud trial

NEW YORK/June 26, 2017 (AP)(STL.News) — Martin Shkreli: “Pharma Bro” just won’t keep his mouth shut. Even with his federal securities fraud trial set to begin Monday, Martin Shkreli has blatantly defied his attorneys’ advice to lay low. The former pharmaceutical CEO, who became a pariah after raising the cost of a life-saving drug 5,000 … Continue reading ‘Pharma Bro’ defies advice to keep quiet before fraud trial